» Articles » PMID: 9358770

Mononuclear Phagocyte Hydrolytic Enzyme Activity Associated with Cerebral HIV-1 Infection

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 1997 Nov 14
PMID 9358770
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

In patients with HIV encephalitis, activated macrophages and microglial cells in the brain are infected by the human immunodeficiency virus (HIV-1). Immune activation can release neurotoxic chemicals including cytokines, free radicals, autocoids, and hydrolytic enzymes. In this study, the presence of hydrolytic enzymes in acquired immune deficiency syndrome (AIDS)-related neurodegeneration was addressed. Activities of four lysosomal hydrolases were assayed in the frontal lobe of 69 males who died with AIDS and 31 age-matched control men. Activities of all four enzymes were increased significantly (1.6 to 3.6 times) in white matter of patients with AIDS. Less pronounced increases were present in cerebral cortex. Of 69 of the subjects with AIDS, 50 (72%), had at least one abnormally active enzyme. Patients with HIV encephalitis and other neuropathological changes were affected as were many subjects without any clear neuropathological anomaly. Lysosomal cathepsin D immunostaining revealed increased lysosomes within perivascular macrophages, multinucleated cells, activated microglial cells, and hypertrophic astrocytes. Increased enzyme activity was correlated significantly with assay results for HIV-1 DNA using the polymerase chain reaction. The release of acid hydrolases associated with cerebral HIV-1 infection could lead to unopposed hydrolysis of matrix and surface proteins. These post-translational disturbances could contribute to white matter and synaptic injury in AIDS.

Citing Articles

Role of endolysosomes and inter-organellar signaling in brain disease.

Afghah Z, Chen X, Geiger J Neurobiol Dis. 2019; 134:104670.

PMID: 31707116 PMC: 7184921. DOI: 10.1016/j.nbd.2019.104670.


Macrophage derived cystatin B/cathepsin B in HIV replication and neuropathogenesis.

Rivera L, Colon K, Cantres-Rosario Y, Zenon F, Melendez L Curr HIV Res. 2014; 12(2):111-20.

PMID: 24862331 PMC: 4122617. DOI: 10.2174/1570162x12666140526120249.


Cathepsin B and cystatin B in HIV-seropositive women are associated with infection and HIV-1-associated neurocognitive disorders.

Cantres-Rosario Y, Plaud-Valentin M, Gerena Y, Skolasky R, Wojna V, Melendez L AIDS. 2013; 27(3):347-56.

PMID: 23291538 PMC: 3593054. DOI: 10.1097/QAD.0b013e32835b3e47.


Dysregulation of macrophage-secreted cathepsin B contributes to HIV-1-linked neuronal apoptosis.

Rodriguez-Franco E, Cantres-Rosario Y, Plaud-Valentin M, Romeu R, Rodriguez Y, Skolasky R PLoS One. 2012; 7(5):e36571.

PMID: 22693552 PMC: 3365072. DOI: 10.1371/journal.pone.0036571.


Insulin-like growth factor 2 receptor is an IFNgamma-inducible microglial protein that facilitates intracellular HIV replication: implications for HIV-induced neurocognitive disorders.

Suh H, Cosenza-Nashat M, Choi N, Zhao M, Li J, Pollard J Am J Pathol. 2010; 177(5):2446-58.

PMID: 20889566 PMC: 2966802. DOI: 10.2353/ajpath.2010.100399.


References
1.
Cohen S, Herndon R, McKhann G . Radioimmunoassay of myelin basic protein in spinal fluid. An index of active demyelination. N Engl J Med. 1976; 295(26):1455-7. DOI: 10.1056/NEJM197612232952604. View

2.
NEURATH H, Walsh K . Role of proteolytic enzymes in biological regulation (a review). Proc Natl Acad Sci U S A. 1976; 73(11):3825-32. PMC: 431226. DOI: 10.1073/pnas.73.11.3825. View

3.
Benuck M, Marks N, Hashim G . Metabolic instability of myelin proteins. Breakdown of basic protein induced by brain cathepsin D. Eur J Biochem. 1975; 52(3):615-21. DOI: 10.1111/j.1432-1033.1975.tb04033.x. View

4.
Cammer W, Bloom B, Norton W, Gordon S . Degradation of basic protein in myelin by neutral proteases secreted by stimulated macrophages: a possible mechanism of inflammatory demyelination. Proc Natl Acad Sci U S A. 1978; 75(3):1554-8. PMC: 411512. DOI: 10.1073/pnas.75.3.1554. View

5.
Boehme D, Umezawa H, Hashim G, Marks N . Treatment of experimental allergic encephalomyelitis with an inhibitor of cathepsin D (pepstatin). Neurochem Res. 1978; 3(2):185-94. DOI: 10.1007/BF00964059. View